Certoparin

Overview

Certoparin is part of the heparins of low molecular weight that presents high activity against the coagulation factor Xa. It is normally used to prevent deep venous thrombosis.

Indication

Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.

Associated Conditions

Deep Vein Thrombosis
Thrombotic events caused by General Surgery
Thrombotic events caused by Mobility decreased
Thrombotic events caused by Stroke, Ischemic

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects	2012/08/08	NCT01660295	Phase 1	Completed	Novartis Pharmaceuticals
Certoparin in Renal Patients Undergoing Hemodialysis	2010/08/11	NCT01179620	Phase 3	Completed	Novartis
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients	2007/03/23	NCT00451412	Phase 3	Completed	Novartis
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients	2006/04/06	NCT00311753	Phase 3	Completed	Novartis Pharmaceuticals
The HIT-TRAP Trial	2005/09/20	NCT00196417	Phase 4	UNKNOWN	University Medicine Greifswald
Atrial Fibrillation Feasibility Certoparin Trial - AFFECT	2005/09/15	NCT00171769	Phase 3	Completed	Novartis

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access